Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04717492 · ClinicalTrials.gov registry record
An Observational Study of Beta-Blocker Use in Patients With COPD and Acute MI
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 584
- Enrollment target
NCT04717492: Completed study, sponsored by University of Minnesota.
NCT04717492 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 584 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04717492 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 584 participants
- Enrollment target
Study Summary
The study is a prospective, observational study of patients admitted to the BLOCK COPD network hospitals with acute AMI and Chronic Obstructive Pulmonary Disease (COPD) to determine the prevalence of COPD in patients admitted to the hospital with an acute myocardial infarction (AMI) and to characterize the phenotypic expression and severity of their underlying lung disease. Patients with will be identified via the EMR. 571 participants will be enrolled.
Primary Outcome
Results of this Aim will provide data about the prevalence of COPD in the hospitalized population with AMI in our network.
Interventions
- OTHER Observational
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 584 participants |
| Start Date | 2020-06-28 |
| Est. Completion | 2022-12-02 |
What the finished NCT04717492 record still lists
NCT04717492 is an observational study that tracks outcomes without assigning an intervention. The registered 584 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Observational is the first listed.
NCT04717492 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04717492 about?
NCT04717492 is a clinical study titled "An Observational Study of Beta-Blocker Use in Patients With COPD and Acute MI". The study is a prospective, observational study of patients admitted to the BLOCK COPD network hospitals with acute AMI and Chronic Obstructive Pulmonary Disease (COPD) to determine the prevalence of COPD in patients admitted to the hospital with an acute myocardial infarction (AMI) and to character...
What is the current status of trial NCT04717492?
This trial is currently completed. The enrollment target is 584 participants. The study started on 2020-06-28. Estimated completion is 2022-12-02.
What interventions are being tested in trial NCT04717492?
The interventions under investigation include: Observational (OTHER).
Who is sponsoring clinical trial NCT04717492?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03840083 · 584 participants · NA
Sleep-dependent Learning in Aging
- NCT04984291 · 584 participants · NA
Zimmer Biomet Shoulder Arthroplasty PMCF
- NCT05983757 · 584 participants · NA
Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe
- NCT06569290 · 584 participants · NA
Refinement and Testing of Recruitment Methodology for Behavioral Medication Adherence Interventions Using Behavioral Science-based Approaches
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI